SyntekaBio (XKRX:226330) Additional Paid-In Capital : ₩92,601.6 Mil(As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Additional Paid-In Capital?

SyntekaBio's quarterly additional paid-in capital increased from Jun. 2023 (₩88,319.3 Mil) to Sep. 2023 (₩94,779.5 Mil) but then stayed the same from Sep. 2023 (₩94,779.5 Mil) to Dec. 2023 (₩92,601.6 Mil).

SyntekaBio's annual additional paid-in capital increased from Dec. 2021 (₩73,427.5 Mil) to Dec. 2022 (₩80,932.6 Mil) and increased from Dec. 2022 (₩80,932.6 Mil) to Dec. 2023 (₩92,601.6 Mil).

SyntekaBio Additional Paid-In Capital Historical Data

The historical data trend for SyntekaBio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Additional Paid-In Capital Chart

SyntekaBio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

70,142.96

71,985.90

73,427.53

80,932.62

92,601.60

SyntekaBio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															80,932.62	80,958.65	88,319.28	94,779.47	92,601.60

SyntekaBio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

SyntekaBio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of SyntekaBio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

SyntekaBio (XKRX:226330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512

Website

http://www.syntekabio.co.kr

SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio (XKRX:226330) Headlines

No Headlines